Publication
Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivo.
Nature communications
Blachier S, Vaney MC, Conquet L, Staropoli I, Fernández I, Giraud E, Arbabian A, Michel V, Szilagyi F, Guez S, Boucharlat A, Chiaravalli J, Tran-Rajau J, Dufour E, Haouz A, Petres S, Planas D, Montagutelli X, Agou F, Lafaye P, Ayme G, Schwartz O, Rey FA, Enninga J, Brelot A